

Net profit for the period increased 23% to ₹38 crores in Q1 FY26, from ₹31 crores in Q1 FY25. Total income for the quarter increased 22% year-on-year to ₹195 crores from ₹160 crores.
Vijaya Diagnostic Centre Ltd is a leading provider of diagnostic services in India. The company offers a comprehensive range of diagnostic services, including pathological investigations and related healthcare services. The company operates within the healthcare sector, specifically focusing on diagnostic services. It was founded in 1981 and has been in business for decades. The company's headquarters is in Hyderabad, Telangana. Vijaya Diagnostic Centre's main products and services include laboratory services and gastroenterology services. The company operates over 95 diagnostic centres spread across 15 cities, offering state-of-the-art facilities and best-in-class diagnostic services. +
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 699.71 | 568.62 | 473.37 | 475.20 | 388.59 |
| Total Expenses | 505.52 | 407.89 | 359.86 | 327.82 | 276.47 |
| Profit Before Tax | 193.16 | 158.68 | 113.51 | 147.38 | 112.12 |
| Profit After Tax | 143.79 | 119.64 | 85.21 | 110.67 | 85.13 |
| Operating Profit After Depreciation | 220.94 | 184.72 | 134.46 | 163.83 | 127.37 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 864.81 | 742.56 | 524.54 | 370.53 | 268.94 |
| Total Non Current Assets | 966.41 | 771.42 | 577.75 | 443.57 | 302.16 |
| Total Current Assets | 307.21 | 211.33 | 275.66 | 269.89 | 239.08 |
| Total Assets | 1,273.62 | 982.75 | 853.41 | 713.46 | 541.24 |
| Total Shareholder's Fund | 795.71 | 657.19 | 544.73 | 468.22 | 359.01 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 224.47 | 183.30 | 164.61 | 158 | 129.64 |
| Net Cash Used In Investing Activities | -181.87 | -140.68 | -109.57 | -123.06 | -129.75 |
| Net Cash Used In Financing Activities | -52.05 | -44.55 | -41.91 | -30.57 | -48.77 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 646.44 | 546.46 | 464.15 | 463.80 | 378.15 |
| Total Expenses | 464.11 | 391.94 | 352.88 | 319.42 | 268.56 |
| Profit Before Tax | 181.30 | 152.47 | 111.27 | 144.38 | 109.59 |
| Profit After Tax | 135.01 | 114.60 | 83.23 | 108.10 | 82.82 |
| Operating Profit After Depreciation | 207.29 | 178.23 | 132.15 | 160.64 | 124.40 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 660.86 | 571.88 | 506.73 | 352.68 | 261.81 |
| Total Non Current Assets | 928.57 | 765.99 | 580.26 | 446.50 | 299.05 |
| Total Current Assets | 295.36 | 196.15 | 269.80 | 264.33 | 234.10 |
| Total Assets | 1,223.93 | 962.14 | 850.06 | 710.83 | 533.15 |
| Total Shareholder's Fund | 783.53 | 653.32 | 545.09 | 469.98 | 360.55 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 206.61 | 174.77 | 162.64 | 155.42 | 127.84 |
| Net Cash Used In Investing Activities | -165.37 | -139.15 | -108.48 | -126.63 | -128.82 |
| Net Cash Used In Financing Activities | -46.84 | -43.35 | -41.26 | -24.72 | -48.19 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 219.38 | 205.21 | 201.56 | 188.05 | 173.24 |
| Total Expenses | 123.86 | 119.15 | 119.73 | 114.52 | 104.38 |
| Profit Before Tax | 64.27 | 58.23 | 57.98 | 52.20 | 47.37 |
| Profit After Tax | 47.93 | 43.18 | 43.28 | 38.59 | 34.86 |
| Operating Profit after Depreciation | 97.92 | 91.16 | 88.08 | 80.58 | 74.41 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 206.27 | 193.08 | 189.35 | 176.73 | 161.64 |
| Total Expenses | 115.07 | 110.40 | 110.84 | 106.64 | 96.81 |
| Profit Before Tax | 68.27 | 59.03 | 57.05 | 52.05 | 45.54 |
| Profit After Tax | 52.65 | 44.21 | 42.70 | 38.75 | 33.42 |
| Operating Profit after Depreciation | 98.43 | 88.23 | 83.66 | 77.32 | 70.32 |
₹2.0/Share
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Apollo Hospitals Enterprise Ltd | ₹8,495.95 | ₹1,22,158.73 |
| Max Healthcare Institute Ltd | ₹1,008.95 | ₹98,195.43 |
| Fortis Healthcare Ltd | ₹988.95 | ₹74,661.59 |
| Aster DM Healthcare Ltd | ₹814.20 | ₹42,185.41 |
| Narayana Hrudayalaya Ltd | ₹1,861.80 | ₹38,047.89 |
| Fund Name | AUM |
|---|---|
| Kotak Small Cap Fund | 4.04% |
| DSP Healthcare Fund | 3.70% |
| Motilal Oswal Small Cap Fund | 3.33% |
| Nippon India Pharma Fund | 3.21% |
| ICICI Pru Innovation Fund | 1.86% |
Vijaya Diagnostic Centre announced its chief technology officer (CTO), Sai Siva Prasad, has resigned from the services of the company due to personal reasons.
10 Jun 2026, 10:43 am
Vijaya Diagnostic Centre announced the resignation of its chief financial officer (CFO), Ankit Shah.
09 Jun 2026, 04:16 pm
Of Rs 2 per share
08 May 2026, 10:09 am
On 7 May 2026
02 May 2026, 11:07 am
On 13 February 2026
06 Feb 2026, 04:17 pm

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.